MM
Mohammad Meesam Khan
About Mohammad Meesam Khan
Data last updated:
Mohammad Meesam Khan is an Additional Director at Aprecia Pharmaceuticals Private Limited (since 2023). The company operates in Business Services. Aprecia Pharmaceuticals Private Limited reported revenue of ₹55.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aprecia Pharmaceuticals Private Limited U74999UP2017PTC093123 | Additional Director | 15 Dec 2023 | 2017 | ₹55.5 Lakh (FY 2024) | Active |
Board colleagues of Mohammad Meesam Khan
| Name | DIN | Company | Designation |
|---|---|---|---|
| Muneeb Alvi | 07137486 | Aprecia Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Mohammad Meesam Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Mohammad Meesam Khan
Mohammad Meesam Khan currently holds 1 directorship: Aprecia Pharmaceuticals Private Limited (Additional Director, since 15 Dec 2023, revenue ₹55.5 Lakh (FY 2024)).
Mohammad Meesam Khan was first appointed on 15 Dec 2023 as Additional Director at Aprecia Pharmaceuticals Private Limited.
The current boards of Mohammad Meesam Khan's companies include Muneeb Alvi (Aprecia Pharmaceuticals Private Limited).